Support MEDICC and our global health equity projects.


MEDICC Review journal features an exclusive interview with the Director of Clinical Research of Cuba’s Molecular Immunology Center, home to innovative cancer vaccines and therapies, including CIMAvax for non-small cell lung cancer, recently cleared for U.S. clinical trials.

Making news here last week: a hemispheric meeting to tackle Zika, a visit by US Secretary of Health & Human Services Sylvia Mathews Burwell, signing of a US-Cuba memorandum to promote joint cancer work, and a top-level scientific meeting on cancer therapies.